Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft Failure

Clinical trial NCT06676696 · RECRUITING

Trial details

NCT number: NCT06676696
Sponsor: Hospital Universitari Vall d'Hebron Research Institute
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Renal Failure , Chronic Graft Failure Graft Rejection Allograft Renal Failure Chronic Requiring Dialysis

Start date: 2024-01-22
Primary completion: 2028-01-31
Enrollment: 202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.